These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 434868)

  • 1. Identification of a neutrophil chemotactic inhibitor in a patient with recurrent pyoderma.
    Robinson LD; Wooten SK; Kelly AP
    Arch Dermatol; 1979 Apr; 115(4):453-7. PubMed ID: 434868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A specific inhibitor of complement (C5)-derived chemotactic activity in serum from patients with systemic lupus erythematosus.
    Perez HD; Lipton M; Goldstein IM
    J Clin Invest; 1978 Jul; 62(1):29-38. PubMed ID: 659635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defective neutrophil motility and recurrent infection. In vitro and in vivo effects of levamisole.
    Rabson AR; Anderson R; Glover A
    Clin Exp Immunol; 1978 Jul; 33(1):142-9. PubMed ID: 709909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro studies on microphage functions in chronic pyoderma vegetans.
    Djawari D; Hornstein OP
    Arch Dermatol Res; 1978 Sep; 263(1):97-104. PubMed ID: 363070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
    Clark RA; Klebanoff SJ
    J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro studies on microphage functions in chronic pyoderma vegetans.
    Djawari D; Hornstein OP
    Arch Dermatol Res; 1978; 263(1):97-104. PubMed ID: 394690
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levamisole in chronic pyoderma.
    Papageorgiou P; Kesarwala HH; Alcid DV; Szep R; Kulkarni KN; Gocke DJ
    J Clin Lab Immunol; 1982 Jun; 8(2):121-7. PubMed ID: 7108939
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defective monocyte function in pyoderma gangrenosum with IgG kappa paraproteinaemia.
    Jones RR; Kobza Black A; Donaghy M; Moshtael O; Pinching AJ
    Clin Exp Immunol; 1983 Jun; 52(3):685-92. PubMed ID: 6409473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A neutrophil chemotactic factor and its inhibitor found in DNCB-induced skin inflammatory lesions.
    Baba T; Tazaki K; Sonozaki H; Torisu M
    J Immunol; 1977 Mar; 118(3):762-8. PubMed ID: 845437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil movement in selected canine skin diseases.
    Latimer KS; Prasse KW; Mahaffey EA; Dawe DL; Lorenz MD; Duncan JR
    Am J Vet Res; 1983 Apr; 44(4):601-5. PubMed ID: 6869956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of aberrant F-actin formation with defective leukocyte chemotaxis and recurrent pyoderma.
    Jung LK
    Clin Immunol Immunopathol; 1991 Oct; 61(1):41-54. PubMed ID: 1959239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The function of microphages in chronic recurrent pyodermias].
    Djawari D
    Z Hautkr; 1980 Jun; 55(11):734-40. PubMed ID: 6998156
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An immunoglobulin (IgG) inhibitor of polymorphonuclear leukocyte motility in a patient with recurrent infection.
    Kramer N; Perez HD; Goldstein IM
    N Engl J Med; 1980 Nov; 303(22):1253-8. PubMed ID: 7421962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of pregnancy serum on polymorphonuclear leukocyte chemotaxis.
    Takeuchi A; Persellin RH
    J Clin Lab Immunol; 1980 Mar; 3(2):121-4. PubMed ID: 7205931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.
    Alper CA; Abramson N; Johnston RB; Jandl JH; Rosen FS
    J Clin Invest; 1970 Nov; 49(11):1975-85. PubMed ID: 4097977
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pyoderma gangrenosum: clinical and laboratory findings in 15 patients with special reference to polyarthritis.
    Holt PJ; Davies MG; Saunders KC; Nuki G
    Medicine (Baltimore); 1980 Mar; 59(2):114-33. PubMed ID: 7360040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonleukoreduced red blood cell transfusion induces a sustained inhibition of neutrophil chemotaxis by stimulating in vivo production of transforming growth factor-beta1 by neutrophils: role of the immunoglobulinlike transcript 1, sFasL, and sHLA-I.
    Ottonello L; Ghio M; Contini P; Bertolotto M; Bianchi G; Montecucco F; Colonna M; Mazzei C; Dallegri F; Indiveri F
    Transfusion; 2007 Aug; 47(8):1395-404. PubMed ID: 17655583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An abnormality of neutrophil adhesion: autosomal recessive inheritance associated with missing neutrophil glycoproteins.
    Kobayashi K; Fujita K; Okino F; Kajii T
    Pediatrics; 1984 May; 73(5):606-10. PubMed ID: 6718115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intrinsic polymorphonuclear chemotactic defect in a boy with chronic granulomatous disease.
    de la Cruz R; Jain M; Hsu K; Lim DT
    Allergol Immunopathol (Madr); 1983; 11(6):457-64. PubMed ID: 6670661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of anti-human neutrophil antibodies in vitro. Quantitative studies.
    Boxer LA; Stossel TP
    J Clin Invest; 1974 Jun; 53(6):1534-45. PubMed ID: 4208468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.